Abstract
Heightened systemic inflammation contributes to cardiovascular (CVD) events in people living with HIV (PLWH), although not all PLWH develop CVD, thus suggesting a genetic modifying role. We examined GCH1 polymorphisms, which have been associated with reduced endothelial function in European populations with CVD and increased inflammation, in a racially diverse cohort of US PLWH initiating antiretroviral therapy (ART). GCH1 polymorphisms differed by race and were not associated with flow-mediated dilation or carotid intima-media thickness before or after 48 weeks of ART.
Original language | English (US) |
---|---|
Pages (from-to) | 1669-1671 |
Number of pages | 3 |
Journal | AIDS |
Volume | 33 |
Issue number | 10 |
DOIs | |
State | Published - Aug 1 2019 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Infectious Diseases